Physics of Biology

   

Clinical Study on Transcranial Magnetoelectric Depression Treatment Instrument Treatmenting Depression

Authors: Wei Zou, Qiang Tang, Zuodong Sun, Kang Li, Wuyi Sun, Wenhua Wang, Xueping Yu, Yanli Xing, Xiuying Teng, Li Zhang, Yan Hou

[Objective] Evaluate on the treatment efficacy and safety for transcranial magnetoelectric depression(insomnia) treatment instrument (brand name:AOBO BAIYOUDU) treatmenting depression. [Methods] Methods 80 patients with mild to moderate depression were double center,randomized, double-blind, placebo controlled clinical trial for 4 weeks, including treatment group and control group, each of 40 case. The patients of treatment group were treated with Transcranial magnetoelectric depression(insomnia) treatment instrument,The patients of control group were simulated treated(music comfort)with Transcranial magnetoelectric depression(insomnia) treatment instrument, The course of treatment was 4 weeks. Hamilton Depression Scale (HAMD24) was used to evaluate the efficacy and safety evaluation. [Results] After treated for 4 weeks, the total efficiency rate and total effective rate of the control group were 5% (2/40) and 35% (14/40) respectively, the total efficiency rate and total effective rate of the control group were 65.00%(26/40)and 80.00%(32/40) respectively; The performance test of total efficiency rate and total effective rate for each group was P<0.0001, and the treatment group was higher than the control group, it prove the treatment group was better than the control group. There was no adverse reaction in the two groups. [Conclusions] Transcranial magnetoelectric depression(insomnia) treatment instrument (brand name:AOBO BAIYOUDU) is safe and effective for the treatment of depression,especially in the depression, guilt, sleep disorders, work and interest, retardation, irritability, anxiety and other major symptoms have been significantly improved.

Comments: 10 Pages.

Download: PDF

Submission history

[v1] 2017-07-03 02:07:44

Unique-IP document downloads: 9 times

Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.

Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.

comments powered by Disqus